DrugDashboards

Testosterone Cypionate

Testosterone Cypionate · TESTOSTERONE CYPIONATE 1000 mg/10mL · Injection, Solution · Intramuscular · Eugia US LLC

NDC 55150-0276-01 · 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price is down 12% over the past year, to $5.00 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$5.00per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.0250per billing unit (1 MG)HCPCS J1071 · Jul 1, 2026
  • Part D plans paid (avg)$8.33per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$2.00$4.00$6.00Jan 2024Sep 2026$5.00
33 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$41.40
Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.025
HCPCS J1071 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$41,570
992 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for testosterone cypionate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $37.01 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA211817
TE code
AO
Approval date
Oct 20, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingApr 10, 2025
    Eugia US LLCcGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Manufacturers of Testosterone Cypionate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Azurity Pharmaceuticals, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Bryant Ranch PrepackTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Xiromed LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Alvogen Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 22, 2026Sep 2, 2026
Asclemed USA, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Cipla USA Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 2000 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 1000 mg/10mLJul 15, 2026Sep 2, 2026
Hospira, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
LSNE, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCTESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Steroid S.p.A.TESTOSTERONE CYPIONATE 25000 g/25000gJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Xiromed LLCTESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
Padagis US LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
Sun Pharmaceutical Industries, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
American Regent, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Testosterone Cypionate — NDC 55150-0276-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55150027601.

Free to cite with attribution — see how the data is put together.